Sopharma Trading will offer shares from its capital to investors on BSE in an SPO. The float price has been set at 5 leva.

The company owns warehouses in seven Bulgarian cities – Sofia, Plovdiv, Varna, Veliko Tarnovo, Burgas, Razlog and Vratsa. The bourse code assigned to the issue is SFTRD.

In the past three years, the company's revenue comes primarily from sales of goods (medicines, medical supplies, vitamins, food supplements and cosmetics). Revenue from the pharmacy and hospital market account for 66% and 21% of the total amount, respectively.

As of 2007 Sopharma Trading offers pre-distribution services (that is storage as well as a list of logistics, marketing and financial services) to local and foreign investors.

2004 sales revenues stood at 66.157 mln leva (33.825 mln euros), and in 2005 at 72.52 mln leva (37.078 mln euros). A year later the revenue reached 139.177 mln leva (71.160 mln euros), and in Jan – Sept 2007 came to 186.686 mln leva (95.451 mln euros).

Sopharma Trading is among the leaders in its field in Bulgaria. The company's market share stood at 15.7% in Q4 2006. On the pharmacy market it holds 13.4% and 28.2% on the hospital market. The company expects 2007 data to show its market share expanding to 20% and sales revenues to 256 mln leva.

Sopharma Trading posted its first profit in 2006 – 256,000 leva, after reporting negative results in the amount of 918,000 leva and 2.132 mln leva for 2005 and 2004, respectively.

Main shareholder is Sopharma Jsc, which controls 99.22% of the capital.